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Figure S1: The open-loop Tat-LTR circuit exhibits a threshold in both activation and mean 
expression.  (A) Flow data from three isoclones of Jurkat Tat-Dendra + LTR mCherry-deg cells, 
as shown in raw form in Fig. 2D and as dose-response plots in Fig. 2E, fit to a Hill function 
(Methods).  The dose-response data and Hill fit lines are depicted for each condition, with Hill 
coefficient (H) and half-maximal binding (K50) values in adjacent tables together with goodness 
of fit (R2).   (B) The equivalent dose-mean expression curves in Fig. 2E were analyzed as in panel 
A.  (C) Data and fits from panel B, with Tat-Dendra on a linear scale to emphasize the weakly 












Figure S2: Extraction and QC of single-cell trajectories from time-lapse images. (A) Jurkat 
Tat-Dendra + LTR mCherry-deg cells underwent time-lapse microscopy to yield the data described 
in Fig. 3.  Briefly, the cells were biotinylated, attached to a streptavidin-coated coverslip, then 
induced with 250 ng/mL Dox and imaged for 20 hours.  Full details of this procedure are in 
Methods.  This two-color fluorescence image is from the final time point of Clone #2, and shows 
one tile of a 5x5 grid.  Tat-Dendra is green; mCherry is magenta.  (B) The same location as (A), in 
brightfield.  Cell locations were marked in brightfield to ensure that dim and non-fluorescent cells 
are fairly represented.  The lower section of the image shows the marked cell centers (white +) 
surrounded by a 23-pixel diameter circle, which is taken as the cell’s area.  Pixels within this area 
contribute to the fluorescence intensity of the cell.  This location is used for all time points to create 
a single-cell trajectory.  (C) To reduce noise in the data, trajectories that showed excessive changes 
between consecutive time points were discarded.  This image shows raw mCherry trajectories from 
Clone #2 undergoing QC.  The maximum percent change between two consecutive time points is 
plotted as a function of maximum intensity, showing that for both dim and bright cells, most have 
a percent change under 10%.  To pass QC, both Dendra and mCherry channels must be under the 
15% noise cutoff shown.  These raw trajectories underwent further QC, smoothing, and bleaching 















Figure S3: Correcting for photobleaching in Tat-Dendra trajectories.  (A) Single-cell 
trajectories were constructed from time-lapse imaging of bright Jurkat Tat-Dendra cells.  For the 
decay curve, cycloheximide was added at t=0 to stop protein synthesis, and images were taken 
every 10 minutes.  For the bleaching curve, the same number of images was taken in 5-second 
intervals to simulate non-decaying protein.  Error bars show 95% CI.  (B) These trajectories were 
fit to simple exponential decay models.  The bleaching half-time was measured at 11.2 hours.  The 
total rate of visible protein decay can be expressed as the sum of the bleaching and degradation 
rates; from this equation, the half-life of Tat-Dendra was calculated at 3.4 hours.  This value was 
confirmed by flow cytometry experiments (data not shown).  To compute the amount of non-
fluorescent protein present, we assume that a fraction of Tat-Dendra enters the bleached state at 















Figure S4: Quantitation of Tat-Dendra by HSV-GFP molecular standard.  (A) HSV-GFP viral 
particles can serve as a “molecular ruler” to convert fluorescence intensity to molecular number.  
Since the HSV capsid protein VP26 is fused to EGFP, and each viral particle assembles into an 
icosahedron with precisely 900 copies of VP26, each viral particle contains 900 EGFP molecules.  
A small portion of a representative image of HSV-GFP is shown; diffraction-limited viral particles 
that were successfully segmented are circled in red.  (B) Histogram of intensities from all viral 
particles (n=5004) that were identified, showing a roughly normal distribution with a mean of 1424 
intensity units per particle.  An increase of one intensity unit corresponds to 23.2 Tat-Dendra 
molecules; this conversion is detailed in Methods. 
 
  
  Figure S5: LTR activation by TNF shortens the lifetime of transient Tat-activation 
threshold. (A) Flow cytometry time-course (as in Fig 2) for Jurkat LTR isoclone #4. Horizontal 
line indicates the mCherry positive cutoff; 10,000 randomly sampled cells displayed. (B) Dose-
response curves for % mCherry positive cells (top) and mCherry MFI (bottom) from data in 
panel A. Individual cells were ranked by Dendra intensity and sorted into 100 bins based on 
percentile. Each bin contained a minimum of 3,000 cells.  Percentage of cells above the mCherry 






Figure S6: The non-physiological activator TSA and the cytokine TNF have distinct effects 
on threshold parameters.  (A) Dose-response curves for %mCherry positive cells from flow 
cytometry measurements of three isoclones of Jurkat Tet-Tat-Dendra + LTR-mCherry, at 20 hours 
post Dox induction in the presence of TSA (trichostatin A, a histone deacetylase inhibitor).  Each 
data point depicts a group of 500 cells.  These data were fit to a Hill function (dashed lines), with 
Hill coefficient (H) and half-maximal binding (K50) values in adjacent table.  Hill fits from Fig. 4 
are presented for comparison.  (B) Dose-response curves from the above experiment, showing 
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Steady state (multisite mass action)
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Saturable multi-site steady state
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